PDB 5tru
PDB Information
| PDB | 5TRU |
| Method | X-RAY DIFFRACTION |
| Host Organism | Cricetulus griseus |
| Gene Source | Homo sapiens |
| Primary Citation | Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab.
Proc. Natl. Acad. Sci. U.S.A.
|
| Header | Immune System |
| Released | 2016-10-27 |
| Resolution | 3.000 |
| CATH Insert Date | 14 May, 2017 |
PDB Images (17)
PDB Prints
PDB Chains (6)
| Chain ID | Date inserted into CATH | CATH Status |
|---|---|---|
| c | 15 May, 2017 | Chopped |
| C | 15 May, 2017 | Chopped |
| h | 15 May, 2017 | Chopped |
| H | 15 May, 2017 | Chopped |
| l | 15 May, 2017 | Chopped |
| L | 15 May, 2017 | Chopped |
CATH Domains (10)
| Domain ID | Date inserted into CATH | Superfamily | CATH Status |
|---|---|---|---|
| 5truc00 | 06 Nov, 2017 | 2.60.40.10 | Assigned |
| 5truC00 | 06 Nov, 2017 | 2.60.40.10 | Assigned |
| 5truh01 | 06 Nov, 2017 | Holding pen | |
| 5truH01 | 06 Nov, 2017 | Holding pen | |
| 5truh02 | 06 Nov, 2017 | 2.60.40.10 | Assigned |
| 5truH02 | 06 Nov, 2017 | 2.60.40.10 | Assigned |
| 5trul01 | 06 Nov, 2017 | 2.60.40.10 | Assigned |
| 5truL01 | 06 Nov, 2017 | 2.60.40.10 | Assigned |
| 5trul02 | 06 Nov, 2017 | 2.60.40.10 | Assigned |
| 5truL02 | 06 Nov, 2017 | 2.60.40.10 | Assigned |
UniProtKB Entries (2)
| Accession | Gene ID | Taxon | Description |
|---|---|---|---|
| P16410 | CTLA4_HUMAN | Homo sapiens | Cytotoxic T-lymphocyte protein 4 |
| P16410 | CTLA4_HUMAN | Homo sapiens | Cytotoxic T-lymphocyte protein 4 |
